The Rainwater Charitable Foundation (RCF) was created in the early 1990s by renowned private equity investor and philanthropist Richard E. Rainwater. RCF supports a range of programs in K–12 education, medical research, and other worthy causes. To deliver on its mission to accelerate the development of new diagnostics and treatments for tau-related neurodegenerative disorders, the Rainwater Charitable Foundation Medical Research team manages the Tau Consortium and the Rainwater Prize Program. With more than $100 million invested to date, the Rainwater Foundation has helped to advance eight treatments into human trials.

CurePSP is a nonprofit advocacy organization focused on progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and other prime-of-life neurodegenerative diseases, a spectrum of fatal brain disorders that often strike during a person’s most productive and rewarding years. Currently, there is no effective treatment or cure for these diseases, which affect more than 150,000 people in the U.S. alone. Since it was founded in 1990, CurePSP has funded more than 200 research studies and is the leading source of information and support for patients and their families, other caregivers, researchers and doctors, and allied healthcare professionals. CurePSP is based in New York City.

The Association for Frontotemporal Degeneration (AFTD) is a Pennsylvania-based, national nonprofit working to improve the quality of life of people affected by FTD, and drive research to a cure. AFTD envisions a world with compassionate care, effective support, and a future free of FTD. Since 2015, AFTD research initiatives and funding partnerships have brought over $18 million in funding for FTD research spanning foundational science, biomarker development, drug development, and clinical trials. We convene a network of volunteer-driven, FTD-specific support groups in states across the country, and our HelpLine ([email protected], 1-866-507-7222) helps thousands each year to navigate the FTD journey.